Trading Signals: UTHR Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)( United Therapeutics Corp)
| UTHR latest price $107.9700 (-1.61%) ($104.6600 - $113.4800) on Wed. Apr. 29, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.85% (three month average) | RSI | 72 | Latest Price | $107.9700(-1.61%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | UTHR advances 6.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support UTHR advance at 0% a week (0% probability) XLV(36%) IBB(31%) XBI(31%) VFMO(30%) VYM(30%) | Factors Impacting UTHR price | UTHR will decline at least -1.925% in a week (0% probabilities). VIXM(-21%) VXX(-16%) UUP(-11%) TLT(-6%) XLC(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.925% (StdDev 3.85%) | Hourly BBV | 0 () | Intraday Trend | 0.1% | | | |
|
5 Day Moving Average | $110.1(-1.93%) | 10 Day Moving Average | $107.29(0.63%) | 20 Day Moving Average | $101.84(6.02%) | To recent high | -6.4% | To recent low | 36% | Market Cap | $4.789b | | | | United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD. |